lbg medical ltd

Live MatureMidRapid

lbg medical ltd Company Information

Share LBG MEDICAL LTD

Company Number

01498237

Shareholders

hampstead limited

andrew barnes

View All

Group Structure

View All

Industry

Manufacture of medical and dental instruments and supplies

 

Registered Address

emerald place emerald way, stone business park, stone, staffordshire, ST15 0SR

lbg medical ltd Estimated Valuation

£5m

Pomanda estimates the enterprise value of LBG MEDICAL LTD at £5m based on a Turnover of £6.2m and 0.82x industry multiple (adjusted for size and gross margin).

lbg medical ltd Estimated Valuation

£0

Pomanda estimates the enterprise value of LBG MEDICAL LTD at £0 based on an EBITDA of £-142.5k and a 4.64x industry multiple (adjusted for size and gross margin).

lbg medical ltd Estimated Valuation

£1.4m

Pomanda estimates the enterprise value of LBG MEDICAL LTD at £1.4m based on Net Assets of £717.2k and 1.97x industry multiple (adjusted for liquidity).

Edit your figures and get a professional valuation report.

Lbg Medical Ltd Overview

Lbg Medical Ltd is a live company located in stone, ST15 0SR with a Companies House number of 01498237. It operates in the manufacture of medical and dental instruments and supplies sector, SIC Code 32500. Founded in May 1980, it's largest shareholder is hampstead limited with a 96% stake. Lbg Medical Ltd is a mature, mid sized company, Pomanda has estimated its turnover at £6.2m with rapid growth in recent years.

View Sample
View Sample
View Sample

Lbg Medical Ltd Health Check

Pomanda's financial health check has awarded Lbg Medical Ltd a 2 rating. We use a traffic light system to show it exceeds the industry average on 3 measures and has 8 areas for improvement. Company Health Check FAQs

Health Check Image
Health Rating2out of 5
positive_score

3 Strong

positive_score

1 Regular

positive_score

8 Weak

size

Size

annual sales of £6.2m, make it smaller than the average company (£17.9m)

£6.2m - Lbg Medical Ltd

£17.9m - Industry AVG

growth

Growth

3 year (CAGR) sales growth of 37%, show it is growing at a faster rate (6.2%)

37% - Lbg Medical Ltd

6.2% - Industry AVG

production

Production

with a gross margin of 24.6%, this company has a higher cost of product (37.4%)

24.6% - Lbg Medical Ltd

37.4% - Industry AVG

profitability

Profitability

an operating margin of -3% make it less profitable than the average company (5.9%)

-3% - Lbg Medical Ltd

5.9% - Industry AVG

employees

Employees

with 42 employees, this is below the industry average (89)

42 - Lbg Medical Ltd

89 - Industry AVG

paystructure

Pay Structure

on an average salary of £49.8k, the company has an equivalent pay structure (£49.8k)

£49.8k - Lbg Medical Ltd

£49.8k - Industry AVG

efficiency

Efficiency

resulting in sales per employee of £146.9k, this is less efficient (£181.5k)

£146.9k - Lbg Medical Ltd

£181.5k - Industry AVG

debtordays

Debtor Days

it gets paid by customers after 106 days, this is later than average (50 days)

106 days - Lbg Medical Ltd

50 days - Industry AVG

creditordays

Creditor Days

its suppliers are paid after 113 days, this is slower than average (35 days)

113 days - Lbg Medical Ltd

35 days - Industry AVG

stockdays

Stock Days

it holds stock equivalent to 34 days, this is less than average (95 days)

34 days - Lbg Medical Ltd

95 days - Industry AVG

cashbalance

Cash Balance

has cash to cover current liabilities for 0 weeks, this is less cash available to meet short term requirements (11 weeks)

0 weeks - Lbg Medical Ltd

11 weeks - Industry AVG

debtlevel

Debt Level

it has a ratio of liabilities to total assets of 70.8%, this is a higher level of debt than the average (41.9%)

70.8% - Lbg Medical Ltd

41.9% - Industry AVG

LBG MEDICAL LTD financials

EXPORTms excel logo

Lbg Medical Ltd's latest turnover from December 2023 is estimated at £6.2 million and the company has net assets of £717.2 thousand. According to their latest financial statements, Lbg Medical Ltd has 42 employees and maintains cash reserves of £10.1 thousand as reported in the balance sheet.

Data source: Companies HousePomanda Estimates

Dec 2023Dec 2022Dec 2021Dec 2020Dec 2019Dec 2018Dec 2017Dec 2016Dec 2015Dec 2014Dec 2013Dec 2012Dec 2011Dec 2010Dec 2009
Turnover6,167,7446,155,6092,327,0342,403,9452,397,5042,180,3512,455,3262,238,7032,040,3022,827,9142,742,2312,818,9342,445,4423,708,3411,709,193
Other Income Or Grants
Cost Of Sales4,650,5074,589,2311,757,4841,795,8271,766,6031,629,7811,836,7351,606,5771,420,6171,964,6681,892,1871,917,6371,654,5522,478,845
Gross Profit1,517,2361,566,378569,550608,118630,901550,570618,591632,126619,686863,245850,044901,296790,8901,229,496
Admin Expenses1,702,5571,684,766659,018714,978620,088357,590360,643557,755673,457-241,669496,012894,5571,444,5411,253,655-178,452
Operating Profit-185,321-118,388-89,468-106,86010,813192,980257,94874,371-53,7711,104,914354,0326,739-653,651-24,159178,452
Interest Payable2,4115,7526,5717,0967,5374,0991,9561,956349349
Interest Receivable1,5286,43251490729654321178542441181798080
Pre-Tax Profit-183,793-111,956-88,954-109,1825,790187,063251,17367,013-57,3281,105,356354,2134,862-655,528-24,429178,103
Tax-1,100-35,542-47,723-13,402-232,125-81,469-1,167-49,869
Profit After Tax-183,793-111,956-88,954-109,1824,690151,521203,45053,610-57,328873,231272,7443,695-655,528-24,429128,234
Dividends Paid
Retained Profit-183,793-111,956-88,954-109,1824,690151,521203,45053,610-57,328873,231272,7443,695-655,528-24,429128,234
Employee Costs2,091,5722,145,2032,077,8192,180,0042,125,9092,150,1622,208,6121,957,9661,632,836493,959471,004502,564427,463635,377
Number Of Employees4244444646475147421313141218
EBITDA*-142,493-65,051-34,300-48,75549,966231,236308,801149,62325,3131,194,847447,30682,090-555,63416,144197,957

* Earnings Before Interest, Tax, Depreciation and Amortisation

Dec 2023Dec 2022Dec 2021Dec 2020Dec 2019Dec 2018Dec 2017Dec 2016Dec 2015Dec 2014Dec 2013Dec 2012Dec 2011Dec 2010Dec 2009
Tangible Assets186,669221,956275,293310,531272,655292,613318,247347,319363,144369,240416,829473,584550,636237,986249,939
Intangible Assets16,46024,00124,00123,35018,9045,8238,98522,33347,88884,277204,921241,088220,321914,629850,507
Investments & Other
Debtors (Due After 1 year)
Total Fixed Assets203,129245,957299,294333,881291,559298,436327,232369,652411,032453,517621,750714,672770,9571,152,6151,100,446
Stock & work in progress445,855456,050372,302395,552397,720396,101347,303368,271310,179335,779340,005407,016325,573249,675238,137
Trade Debtors1,798,2511,860,747418,074440,920422,914358,224424,233417,607378,582801,680652,075623,757531,374849,666670,923
Group Debtors
Misc Debtors1,382,8011,260,6491,258,4171,304,4531,235,434866,247636,292
Cash10,07748,114319,44291,72087,581106,86967,44261,15581,194135,65240,83131,55331,865
misc current assets
total current assets2,254,1832,364,9112,492,6192,188,8412,166,6322,165,6472,074,4121,713,2801,406,2471,273,1111,032,9111,062,326856,9471,131,206909,060
total assets2,457,3122,610,8682,791,9132,522,7222,458,1912,464,0832,401,6442,082,9321,817,2791,726,6281,654,6611,776,9981,627,9042,283,8212,009,506
Bank overdraft13,15412,40412,00411,90410,90460,19710,751
Bank loan
Trade Creditors 1,444,1341,335,554214,697215,430227,798264,505387,933223,193190,773730,358919,9161,071,550957,0501,433,9801,155,241
Group/Directors Accounts
other short term finances
hp & lease commitments
other current liabilities1,134,8581,160,208915,592877,063830,440867,704679,51771,62530,756
total current liabilities1,444,1341,335,5541,349,5551,375,6381,156,5441,153,9721,230,3771,102,801881,194730,358919,9161,071,5501,088,8721,464,7361,165,992
loans65,90678,97591,302103,140115,220
hp & lease commitments
Accruals and Deferred Income
other liabilities255,000333,343388,431126,215142,086167,25821,415
provisions40,95140,95140,95145,15434,91835,00335,35335,82933,31325,17521,00016,87821,41521,415
total long term liabilities295,951374,294429,38245,154100,824113,978126,655138,969148,533151,390163,086184,13621,41521,41521,415
total liabilities1,740,0851,709,8481,778,9371,420,7921,257,3681,267,9501,357,0321,241,7701,029,727881,7481,083,0021,255,6861,110,2871,486,1511,187,407
net assets717,227901,0201,012,9761,101,9301,200,8231,196,1331,044,612841,162787,552844,880571,659521,312517,617797,670822,099
total shareholders funds717,227901,0201,012,9761,101,9301,200,8231,196,1331,044,612841,162787,552844,880571,659521,312517,617797,670822,099
Dec 2023Dec 2022Dec 2021Dec 2020Dec 2019Dec 2018Dec 2017Dec 2016Dec 2015Dec 2014Dec 2013Dec 2012Dec 2011Dec 2010Dec 2009
Operating Activities
Operating Profit-185,321-118,388-89,468-106,86010,813192,980257,94874,371-53,7711,104,914354,0326,739-653,651-24,159178,452
Depreciation35,28745,79647,62750,41633,37434,31937,50538,35841,69853,01157,10765,08680,91738,55618,246
Amortisation7,5417,5417,5417,6895,7793,93713,34836,89437,38636,92236,16710,26517,1001,7471,259
Tax-1,100-35,542-47,723-13,402-232,125-81,469-1,167-49,869
Stock-10,19583,748-23,250-2,1681,61948,798-20,96858,092-25,600-4,226-67,01181,44375,89811,538238,137
Debtors-62,49659,87299,30620,23818,6543,010375,813268,980213,194149,60528,31892,383-318,292178,743670,923
Creditors108,5801,120,857-733-12,368-36,707-123,428164,74032,420-539,585-189,558-151,634114,500-476,930278,7391,155,241
Accruals and Deferred Income-1,134,858-25,350244,61638,52946,623-37,264188,187679,517-71,62540,86930,756
Deferred Taxes & Provisions-4,20310,236-85-350-4762,5168,1384,1754,122-4,53721,415
Cash flow from operations38,778-222,672-140,642175,65930,33066,73133,23332,272-14,211631,960257,018-54,565-749,301156,773394,269
Investing Activities
capital expenditure-20,581-100,427-32,276-9,460-8,433-33,872-36,59978,300-352-19,066283,641-92,472-1,119,951
Change in Investments
cash flow from investments-20,581-100,427-32,276-9,460-8,433-33,872-36,59978,300-352-19,066283,641-92,472-1,119,951
Financing Activities
Bank loans
Group/Directors Accounts
Other Short Term Loans
Long term loans-65,906-13,069-12,327-11,838-12,080115,220
Hire Purchase and Lease Commitments
other long term liabilities-78,343-55,088388,431-126,215-15,871-25,172167,258-21,41521,415
share issue10,289-600,010-222,397375,475693,865
interest1,5286,432514-2,321-5,023-5,917-6,775-7,359-3,557441181-1,877-1,876-269-349
cash flow from financing-76,815-48,656388,945-57,938-18,092-18,244-18,613-19,439-14,552-615,440-247,388165,381373,599-21,684714,931
cash and cash equivalents
cash-38,037-271,328227,7224,139-19,28839,4276,287-20,039-54,45894,8219,27831,553-31,86531,865
overdraft-13,1547504001001,00010,904-60,19760,197-10,75110,751
change in cash-38,037-271,328227,72217,293-20,03839,0276,187-21,039-65,36294,8219,27891,750-92,06242,616-10,751

lbg medical ltd Credit Report and Business Information

Very Low Risk70 - 100
Low Risk50 - 70
Moderate Risk30 - 50
High Risk20 - 30
Very High Risk0 - 20
Get a comprehensive credit check for lbg medical ltd. Get real-time insights into lbg medical ltd's credit score, group structure and payment trends.

From as little as £6.99

This will not impact your credit rating!

View Credit Report Sample

Lbg Medical Ltd Competitor Analysis

competitor_analysis_table_img

Perform a competitor analysis for lbg medical ltd by selecting its closest rivals, whether from the MANUFACTURING sector, other mid companies, companies in ST15 area or any other competitors across 12 key performance metrics.

lbg medical ltd Ownership

LBG MEDICAL LTD group structure

Lbg Medical Ltd has 1 subsidiary company.

Ultimate parent company

HAMPSTEAD LTD

#0093201

1 parent

LBG MEDICAL LTD

01498237

1 subsidiary

LBG MEDICAL LTD Shareholders

hampstead limited 96%
andrew barnes 2%
samuel wright 2%

lbg medical ltd directors

Lbg Medical Ltd currently has 2 directors. The longest serving directors include Mr Andrew Barnes (Jun 2014) and Mr Paul Fenelon (Apr 2020).

officercountryagestartendrole
Mr Andrew Barnes41 years Jun 2014- Director
Mr Paul Fenelon60 years Apr 2020- Director

P&L

December 2023

turnover

6.2m

0%

operating profit

-185.3k

0%

gross margin

24.6%

-3.33%

turnover

Turnover, or revenue, is the amount of sales generated by a company within the financial year.

Balance Sheet

December 2023

net assets

717.2k

-0.2%

total assets

2.5m

-0.06%

cash

10.1k

-0.79%

net assets

Total assets minus all liabilities

lbg medical ltd company details

company number

01498237

Type

Private limited with Share Capital

industry

32500 - Manufacture of medical and dental instruments and supplies

incorporation date

May 1980

age

45

incorporated

UK

ultimate parent company

HAMPSTEAD LTD

accounts

Unaudited Abridged

last accounts submitted

December 2023

previous names

langer (uk) ltd (January 2015)

langer biomechanics group (uk) limited (December 2005)

See more

accountant

-

auditor

-

address

emerald place emerald way, stone business park, stone, staffordshire, ST15 0SR

Bank

-

Legal Advisor

-

lbg medical ltd Charges & Mortgages

A charge, or mortgage, refers to the rights a company gives to a lender in return for a loan, often in the form of security given over business assets.

We found 8 charges/mortgages relating to lbg medical ltd. Currently there are 4 open charges and 4 have been satisfied in the past.

lbg medical ltd Capital Raised & Share Issues BETA

When a company issues new shares, e.g. to new investors following a funding round, it is required to notify Companies House within one month of making an allotment of shares.

Click to start generating capital raising & share issue transactions for LBG MEDICAL LTD. This can take several minutes, an email will notify you when this has completed.

lbg medical ltd Companies House Filings - See Documents

datedescriptionview/download